Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort (Q39210123)
Jump to navigation
Jump to search
scientific article published on 20 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort |
scientific article published on 20 February 2014 |
Statements
1 reference
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort (English)
1 reference
Ethan Basch
1 reference
Howard I Scher
1 reference
Celestia S Higano
1 reference
Nicholas J Vogelzang
1 reference
Karen A Autio
1 reference
Matthew R Smith
1 reference
Antonia V Bennett
1 reference
Aaron L Weitzman
1 reference
Christian Scheffold
1 reference
Christopher Sweeney
1 reference
Dana E Rathkopf
1 reference
David C Smith
1 reference
Daniel J George
1 reference
Andrea L Harzstark
1 reference
A Oliver Sartor
1 reference
Michael S Gordon
1 reference
Johann S de Bono
1 reference
Naomi B Haas
1 reference
Paul G Corn
1 reference
Frauke Schimmoller
1 reference
20 February 2014
1 reference
1 reference
67
1 reference
2
1 reference
310-318
1 reference
Identifiers
1 reference
1 reference